Concepedia

Publication | Open Access

A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

152

Citations

61

References

2017

Year

Abstract

This clinical trial (LEISH1) was registered at EudraCT (2012-005596-14) and ISRCTN (07766359).

References

YearCitations

Page 1